Federal Food, Drug and Cosmetic Act: Hearings Before the Committee on Interstate and Foreign Commerce, House of Representatives, Eighty-second Congress, First Session, on H.R. 3298, a Bill to Amend Section 503(b) of the Federal Food, Drug and Cosmetic Act ...
U.S. Government Printing Office, 1951 - 229 lappuses
Considers legislation to revise prescription drug dispensation regulations.
Lietotāju komentāri - Rakstīt atsauksmi
Ierastajās vietās neesam atraduši nevienu atsauksmi.
action adequate agency amendment American application Association authority bear BECKWORTH believe bill caution CHAIRMAN committee Congress contains Cosmetic Act costs counter counts court court of appeals dangerous decision determine directions dispensed doctor Drug Administration druggist effect evidence Ewing exemption experience fact Federal FISCHELIS Food and Drug give given Guilty HARROP hearing HESELTON interested issued label LARRICK legislation limited manufacturer matter mean medicine misbranded necessary objection opinion oral patient person Pharmaceutical pharmacist pharmacy physician Plea practice prescriber prescription prescription legend present problem procedure profession professional prohibited proposed protection provision question reason record reference refill regulations requirements respect responsibility restricted retail ruling safe section 502 sell sold standard statement Store supervision telephone thing tion trading unless WARNACK WOLVERTON writing written
211. lappuse - ... or otherwise reviewed on the record of an agency hearing provided by statute; or (6) unwarranted by the facts to the extent that the facts are subject to trial de novo by the reviewing court.
168. lappuse - States, from whom he purchases such articles, to the effect that the same is not adulterated or misbranded within the meaning of this Act, designating it.
168. lappuse - No person shall be subject to the penalties of sub-section (a) of this Section, for having violated Section 3 (a) or (c) of this Act if he established a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect that such article is not adulterated or mis-branded within the meaning of this Act, designating this Act.
227. lappuse - Secretary, after investigation, found to be, and by regulations designated as, habit forming; unless its label bears the name, and quantity or proportion of such substance or derivative and in juxtaposition therewith the statement "Warning May be habit forming.
36. lappuse - ... the United States court of appeals for the circuit wherein such person resides or has his principal place of business...
20. lappuse - Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users...
76. lappuse - ... because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use...
212. lappuse - Whether on the record as a whole there is substantial evidence to support agency findings is a question which Congress has placed in the keeping of the Courts of Appeals. This Court will intervene only in what ought to be the rare instance when [during the appellate court proceeding] the standard appears to have been misapprehended or grossly misapplied.